Corporate team advises the shareholders of Owen Mumford on sale to embecta Corp.
Our team has advised the shareholders of Owen Mumford Holdings Limited on its agreement for the sale to embecta Corp. (Nasdaq: EMBC), a global leader in diabetes care technology, in a transaction valued at up to £150 million.
